Clinical trial

Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

NCT00762190

Study summary

ClinicalTrials.gov

Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention TAK-559 and insulin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Insulin Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-11-01

PhasePHASE3

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

TAK-559 and insulinDRUG

InsulinDRUG

Sponsors & collaborators

Takedalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00762190 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.